发布时间:
2018
-
12
-
04
点击次数:
0
Positions：
Founder, President & CEO
Company：
AnHeart Therapeutics Inc.
个人简介：
Dr. Junyuan Wang is a founder of AnHeart Therapeutics Inc. Dr. Wang has strong leadership experience in global clinical development and medical research acquired through his work at Merck Serono, BMS, Wyeth/Pfizer, The Medicines Company, and Merck & Co. His broad drug development experiences including therapeutic areas such as oncology, cardiovascular, neuroscience, immunology, and hematology. He has a stellar track-record in shaping global drug development strategy. He has played critical support for two successful new drug applications in US and worldwide market authorization. One of the product that he led a team of over 20 people to support NDA has reached annual sale of USD 5 Billion in 2017. He also played critical role in many submissions for label extensions. Besides many interaction with health authorities including FDA, EMA, PMDA and CFDA, he also has rich experience in partnering with key opinion leaders and vendors to foster data-driven decision making. He is well recognized for his deep understanding in ICH guidelines, GCP compliance, and trial quality control. He serves as global experts for two CFDA/CDE ICH working groups. He also served leadership role in professional societies and in programming committee of scientific conferences.